GS1 Standard Would Speed The Sale Of Returned Drugs After November Deadline

 
• By Joanne S. Eglovitch

New messaging standard from GS1 would enable industry to sell most returned drugs after November DSCSA deadline without running afoul of the FDA.

Verification
GS1 Official Says New Guideline Should Help Manufacturers Process Salable Returns Quickly • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance